Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-02-13

Clinical Trial Update: The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)

View source ↗

Summary

The Canadian follow-up program for the ATTRACT study in rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid | Status: TERMINATED